Scientists search for clues in blood and tissue to personalize cancer care
NCT ID NCT00628368
Summary
This study aimed to find biological markers in blood and tumor tissue that could help predict how patients with esophageal or rectal cancer will respond to treatment before they start it. Researchers collected samples from 160 patients who were scheduled to receive chemotherapy and radiation before surgery. The goal was to learn more about the disease to potentially guide future, more personalized treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Montpellier, 34298, France
Conditions
Explore the condition pages connected to this study.